Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients
Key facts
- Who runs it
- University of Michigan
- Where
- Albuquerque, Ann Arbor, Atlanta, Aurora, Baltimore, Bay Shore, Birmingham, Boston, Camden, Charlottesville, Chicago, Cincinnati, Cleveland, Clinton Township, Columbus, Dallas, Danville, Denver, Detroit, Durham, Edina, Everett, Gainesville, Greenville, Harrisburg, Honolulu, Houston, Indianapolis, Kansas City, Lexington, Los Angeles, Milwaukee, Minneapolis, New Haven, New York, Oak Lawn, Omaha, Philadelphia, Pittsburgh, Portland, Richmond, Rochester, Royal Oak, Sacramento, Saint Paul, Salt Lake City, San Diego, San Francisco, Sayre, Seattle, Stanford, Stony Brook, Syracuse, The Bronx, Toledo, Torrance, Tucson, Washington D.C., and Winston-Salem, United StatesSee the 76 sites
- Trial code
- Status
- Completed
- People taking part
- 1,158 people enrolled
- Started
- 18 May 2020
- Ended
- 1 Feb 2026
- Type of study
- Interventional, 20 groups
- Treatments tested
- Therapeutic Hypothermia
- Record updated
- 15 July 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Coma after resuscitation from out of hospital cardiac arrest
- Cooled to <34 deg C with 240 minutes of cardiac arrest
- Definitive temperature control applied
- Age ≥ 18 years
- Informed consent from legal authorized representative (LAR) including intent to maintain life support for 96 hours
- Enrollment within 6 hours of initiation of cooling
Who cannot take part
- Pre-existing neurological disability or condition that confounds outcome determination
- Pre-existing terminal illness, unlikely to survive to outcome determination
- Hemodynamic instability
- Planned early withdrawal of life support
- Presumed sepsis as etiology of arrest
- Prisoner
Where in United States
- University of New MexicoAlbuquerque, United States
- University of Michigan HospitalAnn Arbor, United States
- Grady Memorial HospitalAtlanta, United States
- University of Colorado HospitalAurora, United States
- Johns Hopkins HospitalBaltimore, United States
- University of Maryland Medical CenterBaltimore, United States
- South Shore University HospitalBay Shore, United States
- University of Alabama HospitalBirmingham, United States
- Beth Israel Deaconess Medical CenterBoston, United States
- Brigham & Women's HospitalBoston, United States
- Massachusetts General HospitalBoston, United States
- Cooper University HospitalCamden, United States
- University of Virginia Medical CenterCharlottesville, United States
- Northwestern Memorial HospitalChicago, United States
- Rush University Medical CenterChicago, United States
- University of Chicago Medical CenterChicago, United States
- University of Illinois-Chicago HosptialChicago, United States
- University of CincinnatiCincinnati, United States
- MetroHealth Medical CenterCleveland, United States
- University Hospitals Cleveland Medical Center*Cleveland, United States
- Henry Ford Macomb HospitalClinton Township, United States
- OSU East HospitalColumbus, United States
- OSU Wexner Medical CenterColumbus, United States
- Parkland HospitalDallas, United States
- Geisinger Medical CenterDanville, United States
- Denver Health Medical CenterDenver, United States
- Detroit Receiving HospitalDetroit, United States
- DMC Sinai Grace HospitalDetroit, United States
- Henry Ford HospitalDetroit, United States
- Duke University HospitalDurham, United States
- M Health Fairview Southdale HospitalEdina, United States
- Providence Regional Medical Center EverettEverett, United States
- UF Health Shands HospitalGainesville, United States
- ECU Health Medical CenterGreenville, United States
- UPMC HarrisburgHarrisburg, United States
- The Queen's Medical CenterHonolulu, United States
- Memorial Hermann HospitalHouston, United States
- IU Health Methodist HospitalIndianapolis, United States
- University of Kansas Medical CenterKansas City, United States
- University of Kentucky HospitalLexington, United States
- Cedars-Sinai Medical CenterLos Angeles, United States
- Ronald Regan UCLA Medical CenterLos Angeles, United States
- Froedtert HospitalMilwaukee, United States
- Hennepin County Medical CenterMinneapolis, United States
- Yale New Haven HospitalNew Haven, United States
- NYP Columbia University Medical CenterNew York, United States
- NYU Langone Health - Tisch HospitalNew York, United States
- The Mount Sinai HospitalNew York, United States
- Advocate Christ Medical CenterOak Lawn, United States
- University of Nebraska Medical CenterOmaha, United States
- Hospital of the University of PennsylvaniaPhiladelphia, United States
- Penn Presbyterian Medical CenterPhiladelphia, United States
- Temple University HospitalPhiladelphia, United States
- Thomas Jefferson University HospitalPhiladelphia, United States
- University of Pittsburgh Medical CenterPittsburgh, United States
- Adventist HealthPortland, United States
- Maine Medical CenterPortland, United States
- VCU Medical CenterRichmond, United States
- Strong Memorial HospitalRochester, United States
- William Beaumont HospitalRoyal Oak, United States
- UC Davis Medical CenterSacramento, United States
- Regions HospitalSaint Paul, United States
- University of Utah HospitalSalt Lake City, United States
- UC San Diego Medical Center - HillcrestSan Diego, United States
- Zuckerberg San Francisco General HospitalSan Francisco, United States
- Guthrie Robert Packer HospitalSayre, United States
- Harborview Medical CenterSeattle, United States
- Stanford University Medical CenterStanford, United States
- Stony Brook University HospitalStony Brook, United States
- SUNY Upstate Medical UniversitySyracuse, United States
- Montefiore Medical CenterThe Bronx, United States
- Mercy St. Vincent Medical CenterToledo, United States
- Harbor-UCLA Medical CenterTorrance, United States
- Banner University Medical CenterTucson, United States
- George Washington University HospitalWashington D.C., United States
- Wake Forest Baptist Medical CenterWinston-Salem, United States
About the trial
What the trial wants to find out
A multicenter, randomized, adaptive allocation clinical trial to determine if increasing durations of induced hypothermia are associated with an increasing rate of good neurological outcomes and to identify the optimal duration of induced hypothermia for neuroprotection in comatose survivors of cardiac arrest.
The 20 groups in the trial
- 6 hours - shockableTreatment being tested
Participants with shockable initial rhythm will be assigned to receive 6 hours of hypothermia with a target of 33 degrees followed by 6 hours of controlled rewarming.
Treatment: Therapeutic Hypothermia
- 12 hours - shockableTreatment being tested
Participants with shockable initial rhythm will be assigned to receive 12 hours of hypothermia with a target of 33 degrees followed by 12 hours of controlled rewarming.
Treatment: Therapeutic Hypothermia
- 18 hours - shockableTreatment being tested
Participants with shockable initial rhythm will be assigned to receive 18 hours of hypothermia with a target of 33 degrees followed by 18 hours of controlled rewarming.
Treatment: Therapeutic Hypothermia
- 24 hours - shockableTreatment being tested
Participants with shockable initial rhythm will be assigned to receive 24 hours of hypothermia with a target of 33 degrees followed by 24 hours of controlled rewarming.
Treatment: Therapeutic Hypothermia
- 30 hours - shockableTreatment being tested
Participants with shockable initial rhythm will be assigned to receive 30 hours of hypothermia with a target of 33 degrees followed by 24 hours of controlled rewarming.
Treatment: Therapeutic Hypothermia
- 36 hours - shockableTreatment being tested
Participants with shockable initial rhythm will be assigned to receive 36 hours of hypothermia with a target of 33 degrees followed by 24 hours of controlled rewarming.
Treatment: Therapeutic Hypothermia
- 42 Hours - shockableTreatment being tested
Participants with shockable initial rhythm will be assigned to receive 42 hours of hypothermia with a target of 33 degrees followed by 24 hours of controlled rewarming.
Treatment: Therapeutic Hypothermia
- 48 hours - shockableTreatment being tested
Participants with shockable initial rhythm will be assigned to receive 48 hours of hypothermia with a target of 33 degrees followed by 24 hours of controlled rewarming.
Treatment: Therapeutic Hypothermia
- 60 hours - shockableTreatment being tested
Participants with shockable initial rhythm will be assigned to receive 60 hours of hypothermia with a target of 33 degrees followed by 24 hours of controlled rewarming.
Treatment: Therapeutic Hypothermia
- 72 hours - shockableTreatment being tested
Participants with shockable initial rhythm will be assigned to receive 72 hours of hypothermia with a target of 33 degrees followed by 24 hours of controlled rewarming.
Treatment: Therapeutic Hypothermia
- 6 hours - non shockableTreatment being tested
Participants with non-shockable initial rhythm will be assigned to receive 6 hours of hypothermia with a target of 33 degrees followed by 6 hours of controlled rewarming.
Treatment: Therapeutic Hypothermia
- 12 hours - non-shockableTreatment being tested
Participants with non-shockable initial rhythm will be assigned to receive 12 hours of hypothermia with a target of 33 degrees followed by 12 hours of controlled rewarming.
Treatment: Therapeutic Hypothermia
- 18 hours - non-shockableTreatment being tested
Participants with non-shockable initial rhythm will be assigned to receive 18 hours of hypothermia with a target of 33 degrees followed by 18 hours of controlled rewarming.
Treatment: Therapeutic Hypothermia
- 24 hour - non-shockableTreatment being tested
Participants with non-shockable initial rhythm will be assigned to receive 24 hours of hypothermia with a target of 33 degrees followed by 24 hours of controlled rewarming.
Treatment: Therapeutic Hypothermia
- 30 hours - non-shockableTreatment being tested
Participants with non-shockable initial rhythm will be assigned to receive 30 hours of hypothermia with a target of 33 degrees followed by 24 hours of controlled rewarming.
Treatment: Therapeutic Hypothermia
- 36 hours - non-shockableTreatment being tested
Participants with non-shockable initial rhythm will be assigned to receive 36 hours of hypothermia with a target of 33 degrees followed by 24 hours of controlled rewarming.
Treatment: Therapeutic Hypothermia
- 42 hours - non-shockableTreatment being tested
Participants with non-shockable initial rhythm will be assigned to receive 42 hours of hypothermia with a target of 33 degrees followed by 24 hours of controlled rewarming.
Treatment: Therapeutic Hypothermia
- 48 hours - non-shockableTreatment being tested
Participants with non-shockable initial rhythm will be assigned to receive 48 hours of hypothermia with a target of 33 degrees followed by 24 hours of controlled rewarming.
Treatment: Therapeutic Hypothermia
- 60 hours - non-shockableTreatment being tested
Participants with non-shockable initial rhythm will be assigned to receive 60 hours of hypothermia with a target of 33 degrees followed by 24 hours of controlled rewarming.
Treatment: Therapeutic Hypothermia
- 72 hours - non-shockableTreatment being tested
Participants with non-shockable initial rhythm will be assigned to receive 72 hours of hypothermia with a target of 33 degrees followed by 24 hours of controlled rewarming.
Treatment: Therapeutic Hypothermia
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients - A Multicenter, Randomized, Adaptive Clinical Trial to Identify the Optimal Duration of Induced Hypothermia for Neuroprotection in Comatose Survivors of Cardiac Arrest
- Publications
- Duration of Therapeutic Hypothermia After Out-of-Hospital Cardiac Arrest: The ICECAP Randomized Clinical Trial.JAMA, 2026
- Clinicians' Approaches to Prognostication After Traumatic Brain Injury and Cardiac Arrest: A Multi-Hospital, Qualitative Study.Neurocritical care, 2026
- Influence of Cooling duration on Efficacy in Cardiac Arrest Patients (ICECAP): study protocol for a multicenter, randomized, adaptive allocation clinical trial to identify the optimal duration of induced hypothermia for neuroprotection in comatose, adult survivors of after out-of-hospital cardiac arrest.Trials, 2024
- Influence of Cooling duration on Efficacy in Cardiac Arrest Patients (ICECAP): study protocol for a multicenter, randomized, adaptive allocation clinical trial to identify the optimal duration of induced hypothermia for neuroprotection in comatose, adult survivors of after out-of-hospital cardiac arrest.Research square, 2024
- A Simple Risk Score for Predicting Neurologic Outcome in Out-of-Hospital Cardiac Arrest Patients After Targeted Temperature Management.Critical care medicine, 2022
- Record updated
- 15 July 2026